Literature DB >> 17071122

Isolation, characterization and molecular cloning of AnMIP, a new alpha-type phospholipase A2 myotoxin inhibitor from the plasma of the snake Atropoides nummifer (Viperidae: Crotalinae).

Steve Quirós1, Alberto Alape-Girón, Yamileth Angulo, Bruno Lomonte.   

Abstract

A new phospholipase A(2) (PLA(2))-inhibitory protein was isolated from the plasma of Atropoides nummifer, a crotaline snake from Central America. This inhibitor was named AnMIP, given its ability to neutralize the activity of basic PLA(2) myotoxins of its own and related venoms. The cDNA of AnMIP was cloned and sequenced, showing that it belongs to the alpha group of phospholipase A(2) inhibitors (PLIs). AnMIP appears as a homotrimer in the native state, held together by non-covalent forces, with a subunit molecular mass of 22,247-22,301 and an isoelectric point of 4.1-4.7. This trimeric structure is the first observed in a PLIalpha from American crotaline snakes, previously reported only in Asian species. Sequencing, mass spectrometry, and analytical isoelectrofocusing indicated the existence of isoforms, as reported for other PLIalphas isolated from snake plasma. The inhibitory profile of AnMIP showed specificity towards group II PLA(2)s, either belonging to the catalytically-active (D49) or -inactive (K49) subtypes, exemplified in this study by Bothrops asper myotoxin I and A. nummifer myotoxin II, respectively. By phylogenetic analysis it was shown that AnMIP is closely related to CgMIP-II, previously isolated from the plasma of Cerrophidion godmani, showing 93% amino acid sequence identity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17071122     DOI: 10.1016/j.cbpb.2006.09.003

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  6 in total

Review 1.  Endogenous phospholipase A2 inhibitors in snakes: a brief overview.

Authors:  Patrícia Cota Campos; Lutiana Amaral de Melo; Gabriel Latorre Fortes Dias; Consuelo Latorre Fortes-Dias
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2016-12-21

Review 2.  Snake Venom PLA2, a Promising Target for Broad-Spectrum Antivenom Drug Development.

Authors:  Huixiang Xiao; Hong Pan; Keren Liao; Mengxue Yang; Chunhong Huang
Journal:  Biomed Res Int       Date:  2017-11-29       Impact factor: 3.411

Review 3.  Alpha-type phospholipase A2 inhibitors from snake blood.

Authors:  Norival A Santos-Filho; Claudia T Santos
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2017-03-23

4.  Purification and characterization of the first γ-phospholipase inhibitor (γPLI) from Bothrops jararaca snake serum.

Authors:  Caroline Serino-Silva; Karen Morais-Zani; Marcos Hikari Toyama; Daniela de Oliveira Toyama; Henrique Hessel Gaeta; Caroline Fabri Bittencourt Rodrigues; Wéslei da Silva Aguiar; Alexandre Keiji Tashima; Kathleen Fernandes Grego; Anita Mitico Tanaka-Azevedo
Journal:  PLoS One       Date:  2018-03-05       Impact factor: 3.240

Review 5.  Diagnostic and Therapeutic Value of Aptamers in Envenomation Cases.

Authors:  Steven Ascoët; Michel De Waard
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

Review 6.  History of Envenoming Therapy and Current Perspectives.

Authors:  Manuela B Pucca; Felipe A Cerni; Rahel Janke; Erick Bermúdez-Méndez; Line Ledsgaard; José E Barbosa; Andreas H Laustsen
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.